Valerio Therapeutics Société anonyme (EPA:ALVIO)
France · Delayed Price · Currency is EUR 0.3945
-0.0065 (-1.62%)
Oct 22, 2026, 5:35 PM CEST
EPA:ALVIO Market Cap
EPA:ALVIO has a market cap or net worth of €197.03 million as of October 22, 2026. It is the 20,025th most valuable company in the world and the 241st biggest in France. Its market cap has increased by 1,628.04% in one year.
Market Cap
197.03M
Enterprise Value
209.71M
Revenue
5.55M
Global Rank
Country Rank
#241 France
PE Ratio
n/a
ChartMarket Cap Chart
Since December 8, 2005, EPA:ALVIO's market cap has increased from 72.77M to 197.03M, an increase of 170.76%. That is a compound annual growth rate of 4.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 197.03M | 192.07% |
| Dec 31, 2025 | 67.46M | 484.18% |
| Dec 31, 2024 | 11.55M | -54.58% |
| Dec 29, 2023 | 25.42M | 62.58% |
| Dec 30, 2022 | 15.64M | -59.41% |
| Dec 31, 2021 | 38.52M | -25.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 705.30M |
| DBV Technologies | 508.38M |
| Valneva SE | 456.48M |
| Genfit | 448.78M |
| Transgene | 185.14M |
| Innate Pharma | 124.62M |
| Sensorion | 91.22M |
| Cellectis | 68.34M |